We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AstraZeneca PLC 02 January 2025  2 January 2025   Transparency Directive Voting rights and capital  The following notification is made in accordance with the UK Financial Conduct...
AstraZeneca PLC and its Japanese partner Daiichi-Sankyo Co Ltd have withdrawn an application in the European Union fo ...
AstraZeneca PLC 24 December 2024    24 December 2024  Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn  ...
AstraZeneca PLC on Monday said it has received approval in the European Union for Tagrisso, its non-small cell lung c ...
AstraZeneca PLC 23 December 2024   23 December 2024  Tagrisso approved in the EU for patients with unresectable EGFR-mutated lung cancer   First and only EGFR inhibitor and targeted...
Sales in China have suffered for AstraZeneca PLC after the arrest of its country president, the Financial Times repor ...
AstraZeneca PLC 16 December 2024  16 December 2024 07:00 GMT   Non-Executive Board Appointments  AstraZeneca PLC announced today that Rene Haas and Birgit Conix have been appointed as...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 140 | 1.3392003061 | 10454 | 10708 | 10320 | 1204561 | 10543.2348553 | DE |
4 | -28 | -0.263603841085 | 10622 | 10736 | 10084 | 1984664 | 10472.2601864 | DE |
12 | -1184 | -10.0526405162 | 11778 | 12098 | 9670 | 2591280 | 10520.8587645 | DE |
26 | -1536 | -12.6628194559 | 12130 | 13338 | 9670 | 2148912 | 11339.4761669 | DE |
52 | -92 | -0.860939547071 | 10686 | 13338 | 9461 | 2278350 | 11165.4349282 | DE |
156 | 1968 | 22.8147461164 | 8626 | 13338 | 8214 | 2196133 | 10732.1216428 | DE |
260 | 2969 | 38.937704918 | 7625 | 13338 | 5871 | 2281011 | 9564.23786189 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions